The most significant risk factor for hepatocellular carcinoma (HCC) is the presence of cirrhosis or advanced fibrosis of the liver. Liver biopsy was traditionally considered the gold standard for assessing the liver fibrosis burden. Recently, non-invasive methods, particularly transient elastography (TE), have proven effective at measuring fibrosis and determining cirrhosis. Clinical application of TE ranges from measuring fibrosis to predicting long-term prognosis and treatment response. Here, we focus on recent studies on the prognostic value of TE for predicting HCC.
IntroductIon
The degree of fibrosis in patients with chronic liver disease (CLD) is a well-known prognostic factor. 1 Historically, liver biopsy has been the standard method for evaluating liver fibrosis. However, this method is not widely used in clinical practice because of its invasiveness, diversity of sampling, and diagnostic variability. 2 Several non-invasive methods have been studied to overcome these limitations. Serum fibrosis markers or prediction algorithms have shown relatively good predictive power; however, ultrasound elastography using shear wave elastography (SWE) or magnetic resonance elastography (MRE) has almost replaced liver biopsy in the last decade. 3 In particular, transient elastography (TE) (FibroScan ® ; Echosens, Paris, France) is the most widely available liver fibrosis measurement method in clinical practice.
Many studies have reported that liver stiffness measurements (LSMs) using TE can accurately predict liver fibrosis. 4 In recent years, SWE has been used to measure liver stiffness (LS) in real time during ultrasonography. 5 MRE, the most accurate method for evaluating liver fibrosis, has been widely used in various clinical trials as a replacement for liver biopsy. 6 The recent use of these tools has expanded to predict longterm prognosis or the occurrence of hepatocellular carcinoma (HCC). Many studies have shown that these methods might be effective for predicting HCC and assessing fibrosis.
Here we focused on recent studies of the prognostic value of non-invasive methods, mainly TE, for predicting HCC. 
Hepatitis C virus

Hepatitis B virus
Predicting the occurrence of HCC using TE in patients with chronic hepatitis B (CHB) has been the most highly studied field, mainly in Korea. This is thought to be due to the high incidence of hepatitis B virus (HBV) in Northeast Asia, unlike hepatitis C virus (HCV), which has a high incidence in Europe and Japan. Table 2 summarizes studies of the prediction of HCC incidence using TE in CHB patients.
Most of the studies recruited large-scale patients.
In 2011, Jung et al. 11 published a prospective cohort study of 1,130 non-biopsy-proven CHB patients. In a multivariate analysis, patients with a higher LSM (>8 kPa) were at significantly greater risk of HCC development. Furthermore, the incidence of HCC increased as LS values increased (LS value, HCV, hepatitis C virus; HCC, hepatocellular carcinoma; te, transient elastography; ARfI, acoustic radiation force impulse; RNA, ribonucleic acid. Therefore, this is the first report in CHB patients to suggest that LSM could be a useful predictor of HCC development.
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In 2014, Wong et al. 12 developed a model for predicting the incidence of HCC in 1,555 CHB patients; LSM was one of the most important risk factors. In the training cohort, the occurrence of HCC was increased about 3.9 times when LS value was higher than 8 kPa (HR, 3.9; 95% CI, 1.5-9.7; P=0.004). When LS value was higher than 12 kPa, the risk of HCC increased by about 6 times (HR, 6.0; 95% CI, 2.5-14.6; P<0.001).
In 2015, a study on patients with TE-defined subclinical cirrhosis and an LS value more than 13 kPa was published. 13 The incidence of HCC was significantly higher in those with subclinical cirrhosis than in those without cirrhosis (13. In 2016, Seo et al. 16 performed TE using liver biopsy sam- 
Mixed etiology
For studies that do not distinguish between etiologies, cross-sectional studies are most common. Table 3 In 2017, Sugihara et al. 21 published a study in which TE was performed in the Japanese general population aged 40 years and older. In this cross-sectional study of 181 patients, only three patients had HCC. For detecting HCC, the cut-off value of LS value was 5.3 kPa, with a sensitivity of 100%, specificity of 75%, and area under the receiver operating characteristic curve of 0.88; these predictive powers were further increased when LSM and a controlled attenuation parameter (CAP) were combined. Although the number of HCC patients in this study was small, it is meaningful that the research was conducted of the general population.
HCC recurrence after resection or RFA
Previous studies have shown that LSM can predict postoperative failure. Recent studies have examined the relationship between TE and recurrence of HCC after RFA or resec- In patients with CHC, platelet count and the presence of SVR were important predictors of HCC development in addition to LSM. 8 When all three risk factors were present, the incidence of HCC was 59.6%, whereas the risk decreased to 8.2% in the absence of all risk factors. In patients who underwent curative resection, necroinflammatory activity grade II-III, tumor multiplicity, and ICG R15, as noted above, affected late HCC recurrence after curative resection in addition to LSM.
conclusIons
Recent advances in non-invasive methods allow us to predict the occurrence of HCC more easily and accurately. Of the methods now available, TE is an excellent tool for assessing fibrosis degree, and its application has been extended to the prediction of HCC incidence. This usefulness of TE in predicting future HCC was also confirmed by many longitudinal and prospective studies. However, since TE alone currently has limited ability to predict HCC, careful interpretation and other integrating test results should be considered.
More research is needed to determine whether tools other 
